Amaurosis fugax is a common term fraught with different interpretations. Disparities in understanding appear to be related to professional training. A new framework to facilitate interdisciplinary communication and clinical research is presented.
Introduction
Optometrists occasionally encounter patients who report marked, transient visual symptoms. Hypothetical examples include:
• A 26-year-old woman reports periodic 'white out' of the entire visual fields of both eyes that precludes visual resolution of any object during the events. These visual changes pass in approximately 15 min, but are followed by an intense unilateral headache.
• A 63-year-old man reports three occurrences of vision that completely 'blacks out' his right eye during the preceding month. Vision in the left eye is unaffected during these incidents. Carotid auscultation is noteworthy for a bruit on the left side.
• An 81-year-old man presents with a recent history of episodic, short-lived, bilateral scintillating scotomata without associated headache or positional connection. During the acute phase, the patient can see gross hand movements, but is unable to discern large, individual optotypes.
In all three instances, the ophthalmic examination and neurological screenings are typically negative. What do these patients have in common?
The examples demonstrate just a few of the myriad presentations of transient vision loss, but do not necessarily present diagnostic dilemmas. The first example most likely represents classic migraine with visual aura, the second amaurosis fugax (AF) associated with carotid artery occlusive disease (CAOD), and the third is probably related to late-onset acephalgic migraine.
What is not apparent is that the visual symptoms reported in these illustrations may all represent variations of AF. Although AF is often considered to be a darkening or dimming of vision, such a restrictive definition depends more upon which sub-specialist is consulted than on interdisciplinary consensus. Consider the last example above: the cardiologist might deem such a presentation to be related to cardiac insufficiency from valvular disease. The ophthalmologist or optometrist might refer to this as an ophthalmic migraine. The neurologist might stop at a diagnosis of acephalgic migraine, whilst the vascular surgeon may perhaps not consider any of these diagnoses.
A medical literature review for AF reveals highly variable and inconsistent use of the terminology involved. Since diagnosis of these cases depends largely on clinical training, it is therefore intended that this report should serve as an entry point for an interdisciplinary resolution of this lexicon.
Clinically speaking, are the first and third examples veritable AF? More specifically, can AF (1) be bilateral or (2) present as scintillating visual aura -not as profound as dimmed sight or vision that has blacked out or turned gray? The answer to both questions appears to be 'yes', but is entirely dependent upon clinician training and the delineation of AF, so it seems evident that it is time to revisit some basic definitions.
Background
Etymologically, AF derives from the Greek terms amaurosis (amauroein) meaning 'to darken or obscure' and fugax (a Latinised version of the earlier Greek word pheugaleos) indicating 'to flee' or 'fleeting'. Historically, this phrase was used to denote many different kinds of vision problems, but it has acquired a more restrictive connotation in modern times.
Fisher's seminal neurology paper, which appeared in the literature in 1951, 1 associated 'fleeting blindness' with ipsilateral CAOD. Subsequent neurology reports concurred with this monocular designation, 2 and it was re-emphasised in the recommendations of the Amaurosis Fugax Study Group. 3 In the end, however, this was not an exclusive definition as the AF Study Group classified AF to be 'transient monocular visual loss attributed to ischaemia or vascular insufficiency' (italics added), but also acknowledged a form of AF that is bilateral. 3 It should also be stressed that another important neurology study -the North American Symptomatic Carotid Endarterectomy Trial (NASCET) 4 -concurred with this monocular designation. In view of the association of monocular AF with CAOD, vascular surgery has also tended to recognise AF as a unilateral phenomenon. 5, 6 The literature appears to be silent on the presence of patients with bilateral CAOD who might also have reported bilateral, yet asynchronous, AF. Perhaps this consideration may explain a lack of 'bilateral' case reports in the corpora of these disciplines.
Although AF has during the past 60 years become associated with a monocular sensation that is often directly related to CAOD, such restrictive use of the phrase is not ubiquitous. Case reports of 'bilateral amaurosis fugax' appear periodically, but seem more often to be reported in the cardiology literature. 7, 8, 9, 10 Amongst other cardiac sources of bilateral AF, mitral valve prolapse is a common cause of bilateral blurring of vision in older patients, 11 although not necessarily in younger individuals. 12 In older patients, the presumed relative ischaemia stems from decreased blood supply to the level of the Circle of Willis, but can also occur from other cardiac causes. 13 When decreased cardiac output is not aetiologic, the anatomical basis for bilateral AF is more likely from vertebrobasilar insufficiency, as it is this circulation that is responsible for supplying the occipitus with its overlapping visual eye fields.
Ophthalmologists tend to refer to similar cases with bilateral visual symptoms as 'binocular transient vision loss'.
14 AF as briefly characterised by Duke-Elder in the classic ophthalmic reference involves 'temporary obscurations of vision', 15 but did not restrict the occurrence by laterality or extent of vision loss. Ophthalmology has not further delineated AF by laterality or level of vision loss 16 as have other sub-specialties. It has been further suggested that this term is inaccurate in describing instances of complete visual loss. 17 Thus it appears that current clinical interpretation of AF depends on specialty training. In general, neurologists and vascular surgeons associate AF with transient monocular vision loss (completely dark vision) related to ipsilateral CAOD; cardiologists tend to consider AF as transient binocular blurring of vision (not necessarily dark vision) that can be related to cardiovascular insufficiency; and ophthalmologists use AF as a catch-all phrase for many forms of transitory visual change in one or both eyes (across the entire spectrum of light and dark visual compromise). These generalisations are characterised by the patient's subjective degree of reported visual loss during the acute phase of visual symptoms. Owing to the transient nature of AF, nearly all patients with this ocular complaint are evaluated after the visual phenomena have resolved. Therefore it is extremely difficult to determine the extent of vision loss during some AF episodes for the majority of patients. Perhaps this paucity of data -in addition to perceived disparate clinical outcomeshas contributed to a seemingly intuitive separation of patients with dark vision incidents from those with light vision experiences.
Discussion
Visual acuities have occasionally been reported during dark vision events. These indicate either light perception (LP) 18 or no light perception (NLP) 19, 20, 21 during the acute phase of AF. Only Bougousslavsky is from a non-ophthalmology source (cardiology), but these findings reinforce the suggestion that most clinicians associate AF with profound vision loss prior to return to baseline visual status. Vision levels during scintillations appear to be unreported; the literature review for this article revealed no reports addressing AF for blurred vision less than LP or NLP vision.
Rather than considering AF as a pathognomonic occurrence, perhaps the time has come to reconsider it as a symptom of a number of underlying conditions. Even for 'idiopathic' cases, neither light-vision nor dark-vision AF is a normal, expected finding. It may be most instructive to consider AF from the broader standpoint of transience, especially considering the wide-ranging continuum of clinical presentations with variable laterality (monocular vs. binocular), frequency of association (CAOD), degree of vision loss (dim or excessively blurred vision), and the length of vision compromise (a few seconds to a few hours). AF need not be restricted to refer solely to complete vision loss (NLP or LP) -rather is it a transient obscuration of vision (in the broadest interpretation of the Greek terms) with return to baseline function.
There is a great subjective difference between patients who experience bilateral blurring of vision (can still see objects) and those who experience total vision loss (unable to see anything). It seems likely that subjects with more profound decreases in vision (dark vision) would be more apt to seek medical care than those with excessive blurring of vision (the equivalent of being unable to accurately report even the largest visual acuity chart optotypes), perhaps also explaining why vision levels during light-vision events are underreported. This consideration is likewise possibly related to objective morbid outcomes associated with darkvision occurrences as compared with relative benignity of light-vision phenomena.
Whilst most references associate AF with blackening or dimming of vision, this may be too restrictive if one considers the underlying source for the ephemeral visual changes: namely, ischaemia. It seems apparent that either type of visual symptomatology (dimming or excessive blur) is http://www.avehjournal.org doi:10.4102/aveh.v74i1.9
related to a hypoxic antecedent -either of which can produce 'dimmed' or 'blurred' vision in either or both eyes.
AF is most accurately reflective of an ophthalmic transient ischaemic attack (TIA). The American Heart Association and American Stroke Association (AHA and ASA) currently define TIA as 'a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischaemia, without acute infarction'. 22 Clearly, short-lived visual disturbances related to retinal or cortical hypoxia fall into this category and need not be restricted by laterality of symptomatology. Nor does this definition limit retinal ischaemia to internal carotid antecedents. It therefore seems prudent to consider AF as a TIA, regardless of monocular or binocular presentation, or the type of visual symptom. This stance includes the visual spectrum from an aura involving excessively blurred vision (discussed below) through no vision (dim, dark, gray, blackened vision, transient 'blindness') during the acute phase -with return to baseline function. Variability of subjective reports has been noted during migraine and TIA events, 23, 24 and it may be conjectured that visual compromise ultimately depends on the extent of relative oxygen deprivation. Duration of altered sensation -from a few minutes to a few hours -also seems likely to be related to the time interval of cortical ischaemia.
Within this context, the degree of visual symptoms may be considered. AF does not include minimal visual blurring but, rather, significant visual blur (no better than 20 out of 400) in the presence of light-field or positive phenomena. Positive experiences can include migraine auras (scintillations, fortifications, twinkling lights or stars, whiteout, etc.), and represent any addition to the visual perceptual fields. For these presentations, perhaps phos AF would be a more accurate descriptor -phos being the Greek transliteration for 'light,' indicating positive or light portents.
Conversely, dim, dark or gray vision would include darkfield or negative visual sensations -a lack of visual perceptual field stimulation. Skotos is the Greek transliteration of 'dark', and indicates the lack of visual input. Essentially, patients with skotos AF perceive nothing in their visual fields and are describing NLP (or rarely LP) vision. These Greek derivatives for light or dark transient obscurations of vision are analogous to ophthalmic use of descriptors for photopic and scotopic vision. This usage is similarly consistent with neurological designations for positive and negative visual auras associated with migraine events. typical migraine headache with normal neuro-ophthalmic examination between attacks, with 'visual disturbances' including 'blindness'. 26 Whilst the source for retinal migraine is considered to be vasospastic, cases that strictly meet IHS criteria are exceedingly rare, 27 and it has been suggested that the term 'retinal migraine' can be misleading. 28 Because of stringent IHS criteria for retinal migraine, cases of monocular phos AF without concurrent cephalgia may be considered migraine variants.
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Differential diagnosis
Bilateral phos AF associated with cephalgia is considered a harbinger of classic migraine with aura, and is illustrated by the first example in this report. However, when bilateral migraine auras occur without headache, the condition is termed acephalgic migraine. Late-onset cases of acephalgic migraine are not unusual, and are not heralds of cerebrovascular accident (CVA) 29 (the third example above). Rarely, cardiac insufficiency can be associated with these bilateral phenomena, so cardiovascular consultation may be considered in patients with late-onset bilateral auras without hemicranias.
The differential diagnosis of skotos AF also relies on determination of laterality. Unilateral cases are highly suggestive of ipsilateral CAOD and merit carotid studies, although only 20% -50% of patients may have positive findings 30, 31 (this is exemplified by the second example). Bilateral symptoms require further query regarding body positioning. When subjective reports can be linked to postural changes, then orthostatic hypotension is to be expected. Without positional antecedent, then migraine variant and vertebrobasilar insufficiency should be considered, although the medical literature is frustratingly silent on the latter of these two diagnostic possibilities.
Unanswered questions
It should be emphasised that there is an extremely wide variety of temporary visual complaints reported by patients. 32, 33 Variability may be related to physiology, but this is poorly understood at present. The physiological difference between visual complaints reported by patients with phos AF (fleeting light vision) and skotos AF (fleeting dark vision) may be because of the degree of relative ischaemia of involved ocular or cortical tissue. This area remains unstudied.
Furthermore, some cases of AF remain 'idiopathic', even in the presence of comprehensive medical work-up. 3, 34 These enigmatic presentations defy identification of underlying cause or clear association and represent the boundary of current medical knowledge. No source for skotos AF will be discovered in approximately 1 in 10 cases of AF amongst patients under the age of 50, 3 whilst that for older patients is unclear. Aetiologies for phos AF events are unreported.
No individual professional societies have published formal guidelines regarding transient visual symptoms across the entire spectrum of ophthalmic compromise. The Amaurosis Fugax Study Group recommended ophthalmic examination, basic laboratory studies and carotid duplex ultrasonography for skotos AF, and a 13-profession interdisciplinary consensus statement advises cartoid endarterectomy for skotos AF patients when AF is associated with ≥ 70% stenosis by noninvasive imaging 35 for patients with these same complaints.
Conclusion
In fine, AF is not pathognomonic or a final diagnosis in and of itself. AF is best understood as an indicator of underlying disease that represents a spectrum of fleeting visual obscurations ranging from excessive blur to complete vision loss of variable duration, and is characterised by a return to baseline function between episodes. AF phenomena can be positive or light or negative or dark, unilateral or bilateral, and should be considered as an ophthalmic TIA, consistent with the AHA and ASA definition. The underlying theme of AF is simply transience -not laterality or the specific visual symptoms.
As an ocular TIA, AF requires further delineation prior to differential diagnosis of the underlying aetiology.
Understanding these characteristics will assist in the management of these patients who present in the clinics of several different specialists. Redefining AF by separating phos AF from skotos AF might augment clinical communication and help to improve differential diagnoses. An initial scheme for the work-up of these patients is provided, and it is hoped that this will be modified as multidisciplinary, clinical understanding of AF improves. This report is intended to help to bridge interdisciplinary gaps in terminology related to the spectrum of AF as a TIA.
